|
|||||
|
|
The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy. |
|
| Authors: | L Ross M Johnson N Graham M Shaefer M St Clair |
| Affiliation: | Glaxo Wellcome, Inc., Research Triangle Park, North Carolina 27709, USA. llr8156@glaxowellcome.com |
| Abstract: | |
| Keywords: | |